Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS)
CNY 7.56
(-1.05%)
CNY 7.56
(-1.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.03 Billion | 1.66 Billion | 192.62 Million | 249.98 Million | 213.16 Million | 50.68 Million |
| Net Income | 677.95 Million | 1.18 Billion | 106.46 Million | 148.71 Million | 149.55 Million | 42.28 Million |
| Depreciation & Amortization | 855.04 Million | 982.19 Million | 107.92 Million | 87.92 Million | 87.33 Million | 79.3 Million |
| Deferred income taxes | -11.62 Million | -18.14 Million | -14.56 Million | 1.76 Million | 948.88 Thousand | - |
| Stock-based compensation | - | 18.14 Million | 14.56 Million | -1.76 Million | -948.88 Thousand | - |
| Change in working capital | 117.82 Million | -843.39 Million | -20.17 Million | -3.73 Million | -50.14 Million | -107.6 Million |
| Other non-cash items | 1.98 Billion | 340.72 Million | -1.59 Million | 17.08 Million | 26.42 Million | 36.7 Million |
| Investing Cash Flow | -864.59 Million | -788.56 Million | -169.91 Million | -288.31 Million | -272.01 Million | -31.75 Million |
| Investments in PPE | -375.83 Million | -452.34 Million | -205.07 Million | -289.89 Million | -157.4 Million | -33.71 Million |
| Acquisitions | 191.52 Thousand | 13.36 Million | 20.07 Million | 712.21 Thousand | -115.53 Million | 1.21 Million |
| Investment purchases | -2.41 Billion | -1.57 Billion | -11.18 Million | -712.21 Thousand | 157.4 Million | - |
| Sales/Maturities of investments | 1.91 Billion | 1.23 Billion | 2.79 Million | 1.04 Million | 928.51 Thousand | 747.96 Thousand |
| Other Investing Activities | 2.9 Million | -1.82 Million | 23.47 Million | 528.8 Thousand | -157.4 Million | 1.21 Million |
| Financing Cash Flow | -701.71 Million | -606.54 Million | -24.23 Million | 5.96 Million | 226.08 Million | -85.53 Million |
| Debt repayment | -312.08 Million | -189.83 Million | -262.56 Million | -462.7 Million | -182.2 Million | -240.2 Million |
| Dividends payments | -152.22 Million | -367.5 Million | -90.71 Million | -16.5 Million | -13.61 Million | -15.33 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -102.59 Million | -49.2 Million | 255.85 Million | 485.16 Million | 421.9 Million | 170 Million |
| Accounts receivables | 82.67 Million | 296.4 Million | 112.79 Million | -23.29 Million | -53.52 Million | -35.2 Million |
| Accounts payables | -1.02 Billion | -243.24 Million | -260.78 Million | -53.83 Million | 80.31 Million | - |
| Inventory | 1.05 Billion | -878.41 Million | -15.21 Million | 71.63 Million | -77.88 Million | -39.84 Million |
| Other working capital | -1.03 Billion | -18.14 Million | 143.02 Million | 1.76 Million | 948.88 Thousand | -67.75 Million |
| Cash at beginning of period | 1.06 Billion | 661.86 Million | 232.55 Million | 264.91 Million | 97.67 Million | 164.28 Million |
| Cash at end of period | 1.41 Billion | 862.34 Million | 231.03 Million | 232.55 Million | 264.91 Million | 97.67 Million |
| Capital Expenditure | -375.83 Million | -452.34 Million | -205.07 Million | -289.89 Million | -157.4 Million | -33.71 Million |
| Effect of forex changes on cash | -736.23 Thousand | -66.91 Million | 5.55 Million | - | 1.06 | 0.69 |
| Net cash flow / Change in cash | 350.93 Million | 200.48 Million | -1.51 Million | -32.36 Million | 167.23 Million | -66.6 Million |
| Free Cash Flow | 1.65 Billion | 1.21 Billion | -12.45 Million | -39.9 Million | 55.76 Million | 16.97 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 171.05 Million | 254.68 Million | 251.48 Million | 677.95 Million | 188.55 Million | 259.23 Million |
| Depreciation & Amortization | - | 212.84 Million | 212.84 Million | 855.04 Million | 195.63 Million | -460.2 Million |
| Deferred income taxes | - | - | - | -11.62 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 117.82 Million | 1.13 Billion | -638.33 Million |
| Other non-cash items | 1.25 Billion | 603.17 Million | -445.87 Million | 1.98 Billion | 308.24 Million | 2.09 Billion |
| Investing Cash Flow | -410.44 Million | -82.05 Million | -40.7 Million | -864.59 Million | 68.05 Million | -328.66 Million |
| Investments in PPE | -154.85 Million | -93.23 Million | -40.71 Million | -375.83 Million | -236.96 Million | -44.74 Million |
| Acquisitions | -1.8 Million | 11.19 Million | - | 191.52 Thousand | 791.65 Million | 14.31 Thousand |
| Investment purchases | -453.83 Million | -500 Million | -400 Million | -2.41 Billion | -1.06 Billion | -964.98 Million |
| Sales/Maturities of investments | 298.86 Million | 499.99 Million | 400 Million | 1.91 Billion | 571.81 Million | 681.05 Million |
| Other Investing Activities | -100.61 Million | 11.19 Million | 411.88 Thousand | 2.9 Million | 3.18 Million | 1173.58 |
| Financing Cash Flow | -795.13 Million | -355.32 Million | -80.01 Million | -701.71 Million | 116.5 Million | -786.37 Million |
| Debt repayment | -669.29 Million | -304.75 Million | -56.46 Million | -312.08 Million | -384.43 Million | -839.92 Million |
| Dividends payments | -29 Million | -662.45 Million | -31.81 Million | -152.22 Million | -30.7 Million | -37.24 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -96.83 Million | -521.07 Million | -136.48 Million | -102.59 Million | 19.1 Million | 90.79 Million |
| Accounts receivables | - | - | - | 82.67 Million | 82.67 Million | -167.49 Million |
| Accounts payables | - | - | - | -1.02 Billion | - | - |
| Inventory | - | - | - | 1.05 Billion | 1.05 Billion | -470.84 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.24 Billion | 1.05 Billion | 1.41 Billion | 1.06 Billion | 931.91 Million | 698.59 Million |
| Cash at end of period | 1.47 Billion | 1.32 Billion | 1.05 Billion | 1.41 Billion | 1.41 Billion | 828.02 Million |
| Capital Expenditure | -154.85 Million | -93.23 Million | -40.71 Million | -375.83 Million | -236.96 Million | -44.74 Million |
| Effect of forex changes on cash | 11.61 Million | 17.26 Million | 12.52 Million | -736.23 Thousand | 13.45 Million | -15.18 Million |
| Net cash flow / Change in cash | 229.82 Million | 273.28 Million | -365.11 Million | 350.93 Million | 486.62 Million | 129.43 Million |
| Free Cash Flow | 1.26 Billion | 551.77 Million | -235.1 Million | 1.65 Billion | 64.2 Million | 1.21 Billion |
3854
2378
3583
IRB
ATCLF
0206